95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
23.55%
Revenue growth 1.25-1.5x KGC's 17.54%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
29.24%
Gross profit growth at 50-75% of KGC's 52.08%. Martin Whitman would question if cost structure or brand is lagging.
37.10%
EBIT growth 50-75% of KGC's 65.25%. Martin Whitman would suspect suboptimal resource allocation.
37.10%
Operating income growth at 50-75% of KGC's 65.25%. Martin Whitman would doubt the firm’s ability to compete efficiently.
26.98%
Net income growth under 50% of KGC's 67.41%. Michael Burry would suspect the firm is falling well behind a key competitor.
28.00%
EPS growth under 50% of KGC's 63.04%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
28.00%
Diluted EPS growth under 50% of KGC's 64.61%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.12%
Share count expansion well above KGC's 0.21%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.09%
Diluted share count expanding well above KGC's 0.10%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
49.79%
OCF growth under 50% of KGC's 104.09%. Michael Burry might suspect questionable revenue recognition or rising costs.
10.57%
FCF growth under 50% of KGC's 47740.00%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
24.38%
10Y revenue/share CAGR above 1.5x KGC's 4.95%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
22.08%
5Y revenue/share CAGR at 50-75% of KGC's 43.54%. Martin Whitman would worry about a lagging mid-term growth trajectory.
5.86%
3Y revenue/share CAGR at 50-75% of KGC's 11.10%. Martin Whitman would question if the firm lags behind competitor innovations.
26.57%
10Y OCF/share CAGR under 50% of KGC's 373.17%. Michael Burry would worry about a persistent underperformance in cash creation.
46.48%
Below 50% of KGC's 191.79%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
32.07%
3Y OCF/share CAGR 1.25-1.5x KGC's 25.12%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
55.82%
Net income/share CAGR at 50-75% of KGC's 104.38%. Martin Whitman might question if the firm’s product or cost base lags behind.
-56.49%
Negative 5Y net income/share CAGR while KGC is 6307.66%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
32.42%
Positive short-term CAGR while KGC is negative. John Neff would see a clear advantage in near-term profit trajectory.
66.72%
Positive growth while KGC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
27.99%
5Y equity/share CAGR at 75-90% of KGC's 32.39%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
25.20%
3Y equity/share CAGR above 1.5x KGC's 9.61%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
13.23%
Dividend/share CAGR of 13.23% while KGC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
101.95%
Dividend/share CAGR of 101.95% while KGC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
59.08%
3Y dividend/share CAGR of 59.08% while KGC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-26.61%
Firm’s AR is declining while KGC shows 5969593500.00%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-24.39%
Inventory is declining while KGC stands at 4.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.37%
Negative asset growth while KGC invests at 0.44%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.38%
Under 50% of KGC's 2.04%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
269.36%
We have some new debt while KGC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-18.96%
We cut SG&A while KGC invests at 31.15%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.